@article{e3e0764b4f5647539b56361651d532f9,
title = "Phase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data",
author = "Owonikoko, {T. K.} and Papadopoulos, {K. P.} and M. Gil-Martin and V. Moreno and Salama, {A. K.} and E. Calvo and H. Safran and A. Gonz{\'a}lez-Mart{\'i}n and R. Aljumaily and D. Mahadevan and J. Niu and {Kal Mohan}, K. and J. Li and E. Stankevich and M. Mathias and I. Lowy and Fury, {M. G.} and Babiker, {H. M.}",
year = "2018",
month = oct,
day = "1",
doi = "10.1093/annonc/mdy289.048",
language = "English (US)",
volume = "29",
pages = "viii461--viii462",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology",
issn = "0923-7534",
publisher = "Elsevier Ltd",
}